Erdoğan Özgür, MD, Associate Professor of Otorhinolaryngology, is a faculty member in the Department of Otorhinolaryngology at Dokuz Eylül University Faculty of Medicine, İzmir, Türkiye. His clinical practice and academic focus are primarily dedicated to head and neck oncology.

Dr. Özgür completed his PhD in the field of head and neck cancer research, with particular interest in tumor biology and immune checkpoint pathways in laryngeal carcinoma. His research focuses on surgical oncology, prognostic factors, and translational aspects of head and neck malignancies.

He is actively involved in clinical research and surgical management of head and neck cancers and regularly participates in national and international scientific meetings.

Dr Hackman serves as a Distinguished Professor of Head and Neck Surgery at the University of North Carolina and Vice Chair of Inpatient Operations and Quality, as well as Chair of the Patient Care Section for the American Head and Neck Society, and member of the Executive Committee for the Salivary Gland Section of AHNS. He has over 15 years of experience with risk adaptive neoadjuvant therapy prior to surgery for mucosal head and neck cancer, and also pioneers the largest volume in-office sialendoscopy practice in the US.

Dr. Sid Puram is the Lindburg Professor and Chair of the Department of Otolaryngology-Head and Neck Surgery at Washington University in St. Louis. He has also served as the Director of the Head and Neck Tumor Center at Siteman since 2023. Dr. Puram graduated from MIT, followed by an MD-PhD at Harvard Medical School. He went on to residency at Harvard/Massachusetts Eye and Ear with an in-folded postdoctoral fellowship with Drs. Bradley Bernstein and Aviv Regev at the MIT Broad Institute/Massachusetts General. Thereafter, he completed a surgical oncology/microvascular free flap fellowship at the James Cancer Center/Ohio State University. Currently, Dr. Puram maintains a clinical practice focused on head and neck oncologic surgery, including transoral robotic surgery, open skull base approaches, and microvascular reconstruction. His multiple R01-funded group has been a leader in genetic, transcriptional, and epigenetic heterogeneity in head and neck cancer and its relationship to cancer phenotypes including metastasis and treatment response, with pioneering work in single cell sequencing. He has published over 180 peer-reviewed articles, including studies in Nature, Cell, and Nature Genetics, and delivered over 50 invited national and international lectures. He is Co-Chair of the NCI Clinical Proteomic Tumor Analysis Consortium Thyroid Working Group, Co-Chair of the NRG Oncology Head and Neck Translational Committee, Past Chair of the Microvascular Committee for the American Academy of Otolaryngology-Head and Neck Surgery, and an active member of the NCI Recurrent/Metastatic Task Force and NRG Head and Neck Core Committee.